{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T04:26:07Z","timestamp":1771647967287,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"am","delay-in-days":337,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17K10640"],"award-info":[{"award-number":["17K10640"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.clnesp.2025.02.015","type":"journal-article","created":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T12:07:29Z","timestamp":1740226049000},"page":"497-504","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Pretreatment bioelectrical impedance analysis predicts chemotherapy efficacy and toxicity in metastatic colorectal cancer patients"],"prefix":"10.1016","volume":"66","author":[{"given":"Rikako","family":"Kato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3948-5044","authenticated-orcid":false,"given":"Yuji","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiharu","family":"Hiyoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuto","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayuko","family":"Ouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuhiro","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Kosumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kojiro","family":"Eto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Ida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Iwatsuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifumi","family":"Baba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Baba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.clnesp.2025.02.015_bib1","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/jama.2021.0106","article-title":"Diagnosis and treatment of metastatic colorectal cancer: a review","volume":"325","author":"Biller","year":"2021","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.clnesp.2025.02.015_bib2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/1758834011431592","article-title":"Therapeutic strategy in unresectable metastatic colorectal cancer","volume":"4","author":"Chibaudel","year":"2012","journal-title":"Ther Adv Med Oncol"},{"issue":"2","key":"10.1016\/j.clnesp.2025.02.015_bib3","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.21873\/anticanres.13212","article-title":"Prognostic significance of the C-reactive protein-to-albumin ratio in patients with metastatic colorectal cancer treated with trifluridine\/thymidine phosphorylase inhibitor as later-line chemotherapy","volume":"39","author":"Shibutani","year":"2019","journal-title":"Anticancer Res"},{"issue":"23","key":"10.1016\/j.clnesp.2025.02.015_bib4","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.1002\/cncr.32163","article-title":"Targeted therapy for colorectal cancer metastases: a review of current methods of molecularly targeted therapy and the use of t tumor biomarkers in the treatment of metastatic colorectal cancer","volume":"125","author":"Piawah","year":"2019","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.clnesp.2025.02.015_bib5","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1097\/DCR.0000000000000458","article-title":"Prognostic nutritional index predicts severe complications, recurrence, and poor prognosis in patients with colorectal cancer undergoing primary tumor resection","volume":"58","author":"T","year":"2015","journal-title":"Dis Colon Rectum"},{"issue":"7","key":"10.1016\/j.clnesp.2025.02.015_bib6","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.annonc.2022.03.274","volume":"33","author":"Hacker","year":"2022","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.clnesp.2025.02.015_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5604\/01.3001.0015.8570","article-title":"Body composition of patients suffering from pancreatic cancer","volume":"95","author":"Kowalska","year":"2022","journal-title":"Pol Przegl Chir"},{"issue":"1","key":"10.1016\/j.clnesp.2025.02.015_bib8","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/jcsm.13158","article-title":"Deep learning-based assessment of body composition and liver tumour burden for survival modelling in advanced colorectal cancer","volume":"14","author":"Keyl","year":"2023","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"issue":"6","key":"10.1016\/j.clnesp.2025.02.015_bib9","first-page":"2936","article-title":"Selected body composition parameters analysis based on bioelectrical impedance in patients operated for gastrointestinal cancer","volume":"36","author":"Scislo","year":"2022","journal-title":"In\u00a0Vivo (Athens)"},{"issue":"1","key":"10.1016\/j.clnesp.2025.02.015_bib10","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/jcsm.13158","article-title":"Deep learning-based assessment of body composition and liver tumour burden for survival modelling in advanced colorectal cancer","volume":"14","author":"Keyl","year":"2023","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"issue":"4","key":"10.1016\/j.clnesp.2025.02.015_bib11","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/ncp.10947","article-title":"Validation of bioelectrical impedance analysis in the evaluation of body composition in patients with breast cancer","volume":"38","author":"Ba\u015f","year":"2023","journal-title":"Nutr Clin Pract"},{"issue":"2","key":"10.1016\/j.clnesp.2025.02.015_bib12","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1634\/theoncologist.2019-0600","article-title":"Bioelectrical impedance analysis for the assessment of sarcopenia in patients with cancer: a systematic review","volume":"25","author":"Aleixo","year":"2020","journal-title":"Oncologist"},{"issue":"4","key":"10.1016\/j.clnesp.2025.02.015_bib13","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3393\/ac.2022.00262.0037","article-title":"Body composition index obtained by using a bioelectrical impedance analysis device can be a predictor of prolonged operative time in patients undergoing minimally invasive colorectal surgery","volume":"39","author":"Kim","year":"2023","journal-title":"Ann Coloproctol"},{"issue":"3","key":"10.1016\/j.clnesp.2025.02.015_bib14","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3390\/cancers12030557","article-title":"Can bioelectrical impedance analysis and BMI be a prognostic tool in head and neck cancer patients? A review of the evidence","volume":"12","author":"Mantzorou","year":"2020","journal-title":"Cancers"},{"issue":"suppl_2","key":"10.1016\/j.clnesp.2025.02.015_bib15","doi-asserted-by":"crossref","first-page":"ii18","DOI":"10.1093\/annonc\/mdx815","article-title":"Insulin resistance and body composition in cancer patients","volume":"29","author":"Dev","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clnesp.2025.02.015_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2021.111567","article-title":"The clinical application value of the extracellular-water-to-total-body-water ratio obtained by bioelectrical impedance analysis in people with advanced cancer","volume":"96","author":"Zheng","year":"2022","journal-title":"Nutrition"},{"issue":"4","key":"10.1016\/j.clnesp.2025.02.015_bib17","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1089\/jpm.2019.0392","article-title":"Collapse of fluid balance and association with survival in patients with advanced cancer admitted to a palliative care unit: preliminary findings","volume":"23","author":"Amano","year":"2020","journal-title":"J\u00a0Palliat Med"},{"issue":"5","key":"10.1016\/j.clnesp.2025.02.015_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001216","article-title":"Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration","volume":"9","author":"Altman","year":"2012","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.clnesp.2025.02.015_bib19","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/ags3.12728","article-title":"Extracellular water to total body water ratio, a novel predictor of recurrence in patients with colorectal cancer","volume":"8","author":"Horino","year":"2023","journal-title":"Ann Gastroenterol Surg"},{"issue":"8","key":"10.1016\/j.clnesp.2025.02.015_bib20","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.15274","article-title":"Body composition, inflammation, and 5-year outcomes in colon cancer","volume":"4","author":"Fleming","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"7","key":"10.1016\/j.clnesp.2025.02.015_bib21","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s00384-019-03316-z","article-title":"Prognostic impact of the combination of neutrophil-to-lymphocyte ratio and Glasgow prognostic score in colorectal cancer: a retrospective cohort study","volume":"34","author":"Inamoto","year":"2019","journal-title":"Int J Colorectal Dis"},{"issue":"1","key":"10.1016\/j.clnesp.2025.02.015_bib22","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/ijc.30071","article-title":"Nomograms for predicting prognostic value of inflammatory biomarkers in colorectal cancer patients after radical resection","volume":"139","author":"Li","year":"2016","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.clnesp.2025.02.015_bib23","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.clcc.2017.03.015","article-title":"Are markers of systemic inflammation good prognostic indicators in colorectal cancer?","volume":"16","author":"Rossi","year":"2017","journal-title":"Clin Colorectal Cancer"},{"issue":"11","key":"10.1016\/j.clnesp.2025.02.015_bib24","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1097\/DCR.0000000000002059","article-title":"Lymphocyte-to-C-Reactive protein ratio is the most sensitive inflammation-based prognostic score in patients with unresectable metastatic colorectal cancer","volume":"64","author":"Nakamura","year":"2021","journal-title":"Dis Colon Rectum"},{"issue":"1","key":"10.1016\/j.clnesp.2025.02.015_bib25","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1186\/s40064-016-3529-y","article-title":"The significance of the C-reactive protein to albumin ratio as a marker for predicting survival and monitoring chemotherapeutic effectiveness in patients with unresectable metastatic colorectal cancer","volume":"5","author":"Shibutani","year":"2016","journal-title":"SpringerPlus"},{"key":"10.1016\/j.clnesp.2025.02.015_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2024.112363","article-title":"Comparison of bioelectrical impedance analysis and computed tomography for the assessment of muscle mass in patients with gastric cancer","volume":"121","author":"Zuo","year":"2024","journal-title":"Nutrition"},{"issue":"50","key":"10.1016\/j.clnesp.2025.02.015_bib27","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000023642","article-title":"Measurement of body mass by bioelectrical impedance analysis and computed tomography in cancer patients with malnutrition - a cross-sectional observational study","volume":"99","author":"Mueller","year":"2020","journal-title":"Medicine (Baltim)"},{"issue":"6","key":"10.1016\/j.clnesp.2025.02.015_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129742","article-title":"Negative impact of skeletal muscle loss after systemic chemotherapy in patients with unresectable colorectal cancer","volume":"10","author":"Miyamoto","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.clnesp.2025.02.015_bib29","article-title":"CT-based muscle and adipose measurements predict prognosis in patients with digestive system malignancy","volume":"14","author":"Zheng","year":"2024","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.clnesp.2025.02.015_bib30","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1186\/s12885-018-4904-6","article-title":"Bioelectrical impedance analysis for monitoring cancer patients receiving chemotherapy and home parenteral nutrition","volume":"18","author":"Cotogni","year":"2018","journal-title":"BMC Cancer"},{"issue":"22","key":"10.1016\/j.clnesp.2025.02.015_bib31","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.3390\/nu15224792","article-title":"Bioelectrical impedance analysis (BIA) for the assessment of body composition in oncology: a scoping review","volume":"15","author":"Branco","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.clnesp.2025.02.015_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2024.1335052","article-title":"Prognostic value of bioelectrical impedance analysis in head and neck cancer patients undergoing radiotherapy: a VALOR\u00ae study","volume":"11","author":"Prior-S\u00e1nchez","year":"2024","journal-title":"Front Nutr"},{"issue":"1","key":"10.1016\/j.clnesp.2025.02.015_bib33","article-title":"Prognostic value of the combined effect of nutritional status and body water component in patients with colorectal cancer","volume":"13","author":"Liu","year":"2023","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.clnesp.2025.02.015_bib34","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1080\/0886022X.2021.1922442","article-title":"Extracellular water\/total body water ratio as predictor of mortality in hemodialysis patients","volume":"43","author":"P\u00e9rez-Morales","year":"2021","journal-title":"Ren Fail"},{"issue":"8","key":"10.1016\/j.clnesp.2025.02.015_bib35","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1159\/000530991","article-title":"The analysis of muscle volume measured by bioelectrical impedance in patients with hepatocellular carcinoma treated with first-line atezolizumab plus bevacizumab combination therapy or first-line lenvatinib","volume":"101","author":"Chihiro","year":"2023","journal-title":"Oncology"},{"issue":"5","key":"10.1016\/j.clnesp.2025.02.015_bib36","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.clnu.2008.07.010","article-title":"Influence of gender and body composition on hydration and body water spaces","volume":"27","author":"Ritz","year":"2008","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnesp.2025.02.015_bib37","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/6283796","article-title":"Cellular and extracellular components in tumor microenvironment and their application in early diagnosis of cancers","volume":"2020","author":"Wei","year":"2020","journal-title":"Anal Cell Pathol"},{"issue":"7","key":"10.1016\/j.clnesp.2025.02.015_bib38","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.21873\/anticanres.14384","article-title":"The association between extracellular water-to-total body water ratio and therapeutic durability for advanced lung cancer","volume":"40","author":"Noda","year":"2020","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.clnesp.2025.02.015_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0262675","article-title":"The importance of body composition assessment for patients with advanced hepatocellular carcinoma by bioelectrical impedance analysis in lenvatinib treatment","volume":"17","author":"Yamaoka","year":"2022","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.clnesp.2025.02.015_bib40","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/ans.18812","article-title":"The association of body composition on chemotherapy toxicities in non-metastatic colorectal cancer patients: a systematic review","volume":"94","author":"Choi","year":"2024","journal-title":"ANZ J Surg"},{"issue":"4","key":"10.1016\/j.clnesp.2025.02.015_bib41","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/jcsm.12436","article-title":"Skeletal muscle mass loss and dose-limiting toxicities in metastatic colorectal cancer patients","volume":"10","author":"Kurk","year":"2019","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.clnesp.2025.02.015_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.671547","article-title":"Impact of body composition on prognosis and dose-limiting toxicities on metastatic colorectal cancer","volume":"8","author":"da Silva Dias","year":"2022","journal-title":"Front Nutr"},{"issue":"10","key":"10.1016\/j.clnesp.2025.02.015_bib43","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1007\/s10147-019-01460-8","article-title":"Skeletal muscle loss during systemic chemotherapy for colorectal cancer indicates treatment response: a pooled analysis of a multicenter clinical trial (KSCC 1605-A)","volume":"24","author":"Sasaki","year":"2019","journal-title":"Int J Clin Oncol"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457725000786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457725000786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T17:25:24Z","timestamp":1747243524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457725000786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":43,"alternative-id":["S2405457725000786"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2025.02.015","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pretreatment bioelectrical impedance analysis predicts chemotherapy efficacy and toxicity in metastatic colorectal cancer patients","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2025.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}